**PURPOSE:** Skin scarring poses a significant medical burden for tens of millions of patients every year. Recently, *Engrailed1*-positive fibroblasts (EPFs) were shown to be responsible for the majority of scarring on the dorsal skin after embryonic day (e)18.5 in mice. However, comparatively little is known about the postnatal function of *Engrailed1*-negative fibroblasts (ENFs), which are present in all layers of the dermis and are putatively non-scarring. We sought to characterize the ENF lineage and assess if ENF-mediated wound healing leads to more ordered repair of skin with regeneration of dermal appendages.

**METHODS:** Experiments were performed in *En1*^*Cre*^*;R26*^*mTmG*^ *(En1*^*mTmG*^) and *En1*^*Cre*^*;Ai6 (En1*^*Ai6*^) mice, with *Engrailed1*-positive cells expressing GFP and *Engrailed1*-negative cells expressing RFP or no reporter, respectively. Postnatal (p) 30 mice underwent dorsal excisional wounding, and healed wound histology was assessed at 2 or 4 weeks. For mechanotransduction inhibition, the wound bed was injected with 30 uL of 50 uM Verteporfin in PBS. *Engrailed1*-negative fibroblasts were isolated from whole dorsal p1 skin using fluorescence-activated cell sorting (FACS). *In vivo* behavior of ENFs was assessed by injecting FACS-sorted ENFs into p30 mouse dorsal skin 2 days prior to wounding. Transcriptomic analysis of ENFs and EPFs was performed using RNA-sequencing of plated cells.

**RESULTS:** FACS-isolated ENFs from p1 mice activate *Engrailed1* after 7 days of culture on plastic. However, ENFs do not activate *Engrailed1 in vitro* after inhibition of stiffness sensing (ROCK inhibitor Y-27632) or culture in soft three-dimensional collagen hydrogels, suggesting a mechanotransduction-mediated mechanism for postnatal *Engrailed1* expression. Postnatal ENFs transplanted into dorsal skin also show activation of *Engrailed1* after wounding. Transcriptomic analysis by RNA-sequencing reveals that postnatal ENF to EPF transition is accompanied by expression of genes related to fibrosis (e.g., WNT/TGFb) and mechanotransduction signaling, including several target genes of Yes-associated protein (YAP). Accordingly, wounds treated with a single administration of YAP inhibitor Verteporfin yield scars with markedly fewer EPFs, reduced fibrosis, and greater ENF presence at 2 weeks. After 4 weeks, Verteporfin-treated wounds show sustained presence of ENFs, as well as regeneration of dermal appendages.

**CONCLUSIONS:** Postnatal ENFs activate *Engrailed1 in vitro* by canonical mechanotransduction signaling and take on a fibrotic phenotype; a similar process occurs in the *in vivo* wound environment. We demonstrate that inhibition of YAP signaling promotes ENF-mediated wound healing with reduced fibrosis and regeneration of secondary elements. Our findings suggest that ENFs may play a critical role in scarring by activating *Engrailed1* in response to mechanical cues within the wound bed. Considering that the *Engrailed1-negative* lineage represents several distinct subpopulations of cells, we aim to assess postnatal *Engrailed1* activation in the papillary, reticular, and hypodermal layers to identify a specific ENF population that contributes to scarring.
